Nutex Health, Inc.
General ticker "NUTX" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $454.5M (TTM average)
Nutex Health, Inc. follows the US Stock Market performance with the rate: 19.7%.
Estimated limits based on current volatility of 7.3%: low 122.53$, high 141.79$
Factors to consider:
- Total employees count: 9 as of 2009
- Current price 189.8% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [19.94$, 54.10$]
- 2025-12-31 to 2026-12-31 estimated range: [13.99$, 39.21$]
Financial Metrics affecting the NUTX estimates:
- Positive: with PPE of 3.4 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 27.22 > 18.64
- Positive: Operating cash flow per share per price, % of 14.60 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 22.33 <= 41.86
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.69 > 6.04
- Negative: Investing cash flow per share per price, % of -1.68 <= -0.66
Short-term NUTX quotes
Long-term NUTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $219.29MM | $247.65MM | $479.95MM |
| Operating Expenses | $625.89MM | $279.42MM | $349.33MM |
| Operating Income | $-406.60MM | $-31.77MM | $130.62MM |
| Non-Operating Income | $-13.05MM | $-16.72MM | $-20.87MM |
| Interest Expense | $12.49MM | $16.32MM | $19.93MM |
| Income(Loss) | $-419.65MM | $-48.49MM | $109.75MM |
| Taxes | $13.09MM | $-5.07MM | $14.48MM |
| Profit(Loss)* | $-424.78MM | $-45.79MM | $52.18MM |
| Stockholders Equity | $95.86MM | $61.45MM | $146.34MM |
| Assets | $431.75MM | $398.25MM | $655.32MM |
| Operating Cash Flow | $50.61MM | $1.26MM | $23.15MM |
| Capital expenditure | $14.63MM | $9.50MM | $2.30MM |
| Investing Cash Flow | $-4.34MM | $-11.24MM | $-2.67MM |
| Financing Cash Flow | $-48.13MM | $-2.27MM | $1.09MM |
| Earnings Per Share** | $-100.50 | $-10.39 | $10.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.